05.06.2017 16:09:00

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Oramed Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, June 5, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP).

If you are a shareholder of Oramed Pharmaceuticals Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:

http://pjlfirm.com/oramed-pharmaceuticals-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http://pjlfirm.com.  Attorney advertising. Prior results do not guarantee a similar outcome. 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-purcell-julie--lefkowitz-llp-is-investigating-oramed-pharmaceuticals-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-300468572.html

SOURCE Purcell Julie & Lefkowitz LLP

Nachrichten zu Oramed Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Oramed Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Oramed Pharmaceuticals Inc 2,24 -0,71% Oramed Pharmaceuticals Inc